companydata.dkELDON BIOLOGICALS A/S: Financial statements 2014
CVR: 26747007
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 4,901,318 and a net result of DKK 1,067,436 compared with DKK 948,720 the year before. That is an increase of 19.8% compared with the year before. Equity amounted to DKK -1,182,839.
- Gross Profit
- 4,901,318 kr.
- Profit/Loss
- 1,067,436 kr.
- Equity
- -1,182,839 kr.
- Total Assets
- 4,899,262 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 4.9 mio. | 1.1 mio. | -1.2 mio. | - |
| 2013 | - | 4.1 mio. | 949 t. | -2.3 mio. | - |
Keep an eye on ELDON BIOLOGICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
As of September 2, 2014, REVISIONSFIRMAET SLEIMANN ApS has been appointed auditor of ELDON BIOLOGICALS A/S.
As of September 2, 2014, V & CO STATSAUTORISERET REVISIONSANPARTSSELSKAB has stepped down as auditor of ELDON BIOLOGICALS A/S.
About ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees. In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity amounted to DKK 42,055,949.